Correlation Between SAB Biotherapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and SAB Biotherapeutics.
Diversification Opportunities for SAB Biotherapeutics and SAB Biotherapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SAB and SAB is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and SAB Biotherapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 28.14 times more return on investment than SAB Biotherapeutics. However, SAB Biotherapeutics is 28.14 times more volatile than SAB Biotherapeutics. It trades about 0.2 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.05 per unit of risk. If you would invest 2.51 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 4.32 from holding SAB Biotherapeutics or generate 172.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 83.33% |
| Values | Daily Returns |
SAB Biotherapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| SAB Biotherapeutics |
SAB Biotherapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and SAB Biotherapeutics
The main advantage of trading using opposite SAB Biotherapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |